Trillium Therapeutics (TRIL) – Corporate News
-
Trillium Therapeutics (TRIL) Shareholders Approve Takeover by Pfizer
-
Trillium Therapeutics (TRIL) Acquired by Pfizer (PFE) for $2.26B or $18.50/sh
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TRIL Stock Lookup